Alterity Therapeutics Limited Gains 146.09%

Alterity Therapeutics Limited (ATHE:NASDAQ) soared at $2.83, representing a gain of 146.1%. On Fri 13 Nov 20, ATHE:NASDAQ touched a New 2-Week Low of $1.15. The stock appeared on our News Catalysts scanner on Mon 16 Nov 20 at 01:46 PM in the 'PATENT' category. From Fri 30 Oct 20, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue 04 Aug 20 at $5.15 with a volume of 110M+, and its share price has been moving sideways in recent weeks.

About Alterity Therapeutics Limited (ATHE:NASDAQ)

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.